Drug Approvals

Nemluvio: a New Way to Treat Chronic Itchy Skin Condition

Nemluvio: a New Way to Treat Chronic Itchy Skin Condition

What is the name of the drug and what does it do? Nemluvio (pronounced Nem-LOO-vee-oh), generic name nemolizumab-ilto, is a medication used to treat adults with prurigo nodularis. This is a chronic skin condition that causes extremely itchy, hard bumps to form on the skin. Nemluvio helps reduce itchiness and improves the appearance of the skin by targeting the...

Advancing Care for Chronic Graft-Versus-Host Disease with Niktimvo

Advancing Care for Chronic Graft-Versus-Host Disease with Niktimvo

What is the name of the drug and what does it do? Niktimvo (pronounced nik-TIM-voh), generic name axatilimab-csfr, is a prescription medicine used to treat chronic graft-versus-host disease (cGVHD). It is approved for adults and children weighing at least 40 kilograms (88.2 pounds) after at least two prior treatments for cGVHD have not worked. cGVHD is a condition...

Meet Cobenfy: The Next Step Forward in Schizophrenia Treatment

Meet Cobenfy: The Next Step Forward in Schizophrenia Treatment

What is the name of the drug and what does it do? Cobenfy (pronounced co-BEN-fee), generic name xanomeline and trospium chloride, is a prescription medication approved on September 26, 2024 to treat schizophrenia in adults. Schizophrenia is a mental health condition that affects how a person thinks, feels, and behaves, often causing hallucinations, delusions, and...

Introducing Flyrcado: A Breakthrough Diagnostic Tool for Heart Health

Introducing Flyrcado: A Breakthrough Diagnostic Tool for Heart Health

What is the name of the drug and what does it do? Flyrcado (pronounced FLYR-ca-doh), generic name flurpiridaz F 18, is a radioactive diagnostic drug approved on September 27, 2024, used for positron emission tomography (PET) myocardial perfusion imaging (MPI). It is designed to help doctors evaluate blood flow in the heart (myocardial perfusion) and detect areas of...